tipranavir (aptivus) Report issue

Small molecule Approved FDA Accelerated Approval FDA Priority Review FDA
Back

Drug Pricing Summary

VA FSS

$4.3367 - $9.5784

AUS PBS

$4.7329

NADAC

$14.7721

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
tipranavir 100 mg / 1 mL (1 mL SOLUTION) $4.3367 VA FSS
  • Aptivus (95)
  • Boehringer Ingelheim Pharmaceuticals, Inc.
    tipranavir 250 mg (CAPSULE) $4.7329 AUS PBS generic
  • Aptivus (120)
  • Boehringer Ingelheim Pty Ltd
    tipranavir 250 mg (CAPSULE) $9.5784 VA FSS
  • Aptivus (120)
  • Boehringer Ingelheim Pharmaceuticals, Inc.
    tipranavir 250 mg (CAPSULE) $14.7721 NADAC brand
  • Aptivus (1)
  • Boehringer Ingelheim Pharmaceuticals, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue